McKesson Corp.

Sector and Industry

Healthcare, Healthcare Services

Performance (1Y)

0.29%

Market Cap

75.92 Bil.

P/E Ratio

22.55

Dividend Yield

0.37 %

Earnings per Share

33.11 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
UnitedHealth Group Inc.254.66 Bil.396.73 Bil.24.94
-19.75 %
0.00
-
Thermo Fisher Scientific Inc.185.62 Bil.39.50 Bil.32.67
+1.45 %
0.00
-
Danaher Corp.137.79 Bil.21.78 Bil.45.36
-11.47 %
0.00
-
McKesson Corporation90.13 Bil.348.09 Bil.22.55
+33.83 %
0.00
-
HCA Healthcare Inc.89.28 Bil.67.01 Bil.16.48
+12.93 %
0.00
-
Elevance Health Inc.65.88 Bil.176.51 Bil.13.91
-9.22 %
0.00
-
The Cigna Group61.74 Bil.243.65 Bil.12.41
+66.33 %
0.00
-
Cencora Inc.51.58 Bil.291.15 Bil.39.26
+1.16 %
0.00
-
IDEXX Laboratories Inc.45.92 Bil.3.81 Bil.51.74
+14.41 %
0.00
-
Zoetis Inc.45.52 Bil.8.39 Bil.20.89
+3.10 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE636.8 G0 Units
PRICE DETERMINATION TIME06/03/2026 / 09:56:47 PM
DAILY VOLUME (UNITS)38
DAILY HIGH / LOW638.8628.8
PREV. DAY'S PRICE631.6 (06/02)
CHANGE DAY BEFORE
+5.20
0.82 %
52 WEEK HIGH / LOW860.8 (03/04)562.8 (08/13)

Key Figures (in EUR)

2027e2026e202520242023
EARNINGS PER SHARE42.9737.8833.1123.9720.64
DIVIDENDS PER SHARE3.073.062.742.562.21
DIVIDEND YIELD IN %--0.37 %0.41 %0.45 %
DIVIDEND GROWTH IN %--6.75 %15.78 %10.16 %
PRICE - EARNINGS RATIO15.1017.1322.5526.1623.98
PRICE - BOOK RATIO-----
PRICE - SALES RATIO--0.270.240.23
PRICE - CASH FLOW RATIO--17.4514.1716.69
Further Key Figures

Master Data

WKN
893953
ISIN
US58155Q1031
SYMBOL
MCK
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
McKesson
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
US Dollar
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Healthcare Services
NUMBER OF SHARES
120.20 Mil.
MARKET CAPITALISATION
75.92 Bil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-2.59 %
-8.86 %
-25.38 %
-13.48 %
0.29 %
73.52 %
303.45 %
-10.11 %
HIGH653.80693.80860.80860.80860.80860.80860.80860.80
LOW626.60615.00615.00615.00562.80357.00154.75615.00
Dividend
per share

Company profile

McKesson Corp. engages in providing healthcare services. It operates through the following segments: North American Pharmaceutical, Oncology and Multispecialty, Prescription Technology Solutions (RxTS), and Medical-Surgical Solutions. The North American Pharmaceutical segment focuses on distribution of branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs to customers in U.S. and Canada. The Oncology and Multispecialty segment includes provision of solutions that includes specialty drug distribution, group purchasing organizations, infusion services, direct to patient pharmacy capabilities, InspiroGene cell and gene therapy services, technology solutions, practice consulting services, and vaccine distribution. The RxTS segment focuses on solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.